Oct 13, 2022 05:24PM

Mar 15, 2022 07:00AM

Mar 15, 2022 07:00AM

Jan 25, 2022 07:06AM

Jan 25, 2022 07:00AM

Jan 25, 2022 07:00AM

Dec 13, 2021 07:02AM Imara Inc. (IMRA) Reports Clinical and Preclinical Tovinontrine (IMR-687) Data

Dec 13, 2021 07:00AM

Dec 13, 2021 07:00AM

Nov 22, 2021 07:02AM

Nov 22, 2021 07:00AM

Nov 22, 2021 07:00AM

Nov 16, 2021 07:05AM

Nov 16, 2021 07:00AM Imara Announces Interim Analysis Data from Forte Phase 2b Clinical Trial of Tovinontrine (IMR-687) in Transfusion-Dependent Subjects with Beta-thalassemia

Nov 16, 2021 07:00AM

Aug 6, 2021 07:00AM

Aug 6, 2021 07:00AM

Jun 11, 2021 03:00AM

Jun 11, 2021 03:00AM

Mar 5, 2021 07:00AM

Jan 20, 2021 07:00AM Imara Announces the Appointment of Kenneth Attie, M.D. as Chief Medical Officer

Nov 5, 2020 07:00AM

Nov 5, 2020 07:00AM

Aug 25, 2020 07:02AM

Aug 25, 2020 07:00AM

Aug 25, 2020 07:00AM

Aug 14, 2020 07:00AM

Jul 30, 2020 07:29AM Imara Inc. (IMRA) Announces IMR-687 Granted Fast Track Designation and Rare Pediatric Disease Designation for Treatment of Beta-Thalassemia

Jul 30, 2020 07:00AM

Jul 30, 2020 07:00AM

Jun 24, 2020 07:04AM

Jun 24, 2020 07:00AM

Jun 24, 2020 07:00AM

Jun 12, 2020 07:01AM

Jun 12, 2020 07:00AM Imara Presents Positive Interim Results from Phase 2a Study of IMR-687 in Sickle Cell Disease at the Virtual European Hematology Association Annual Congress

Jun 12, 2020 07:00AM

322,199 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All